Login / Signup

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma.

Shuang WuYe ZhouHai-Ying HuaYan ZhangWen-Yan ZhuZhi-Qing WangJin LiHua-Qiang GaoXiao-Hong WuTing-Xun LuDong Hua
Published in: BMC cancer (2018)
High ESR in DLBCL patients indicated unfavorable prognosis that may require alternative treatment regimens.
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • estrogen receptor
  • prognostic factors
  • patient reported outcomes
  • patient reported